| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |